Kitazato Corporation manufactures and distributes medical equipment. The Company produces infertility treatment equipment. Kitazato also sells reagent products.

Consolidated Financial Results For The Six Months Ended September 30, 2025 (Under Japanese Gaap)

Consolidated Financial Results For The Three Months Ended June 30, 2025 (Under Japanese Gaap)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kitazato (368A JP)

Consolidated Financial Results For The Six Months Ended September 30, 2025 (Under Japanese Gaap)

Consolidated Financial Results For The Three Months Ended June 30, 2025 (Under Japanese Gaap)

Notice Of Resignation Of Corporate Auditor

Notice On The Company’S Financial Information, Etc. In Line With Its Listing On The Tse Prime Market

Notice Concerning Change Of Controlling Shareholder Other Than Parent Company And Major Shareholder

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)